The small molecule inhibitor DCZ0415 targeting TRIP13 has been reported to restrain the multiplication ability of multiple myeloma cells, colorectal cancer cells, pancreatic ductal adenocarcinoma cells, and lung adenocarcinoma cells. The gene discussed is TRIP13; the disease is plasma cell myeloma.